Overview

Gender

male

Jim has over 25 years in the pharmaceutical industry. Jim founded and was CEO and Chairman of Octagon Research Solutions, Inc. (Octagon), a global pharmaceutical services and software company. Octagon was acquired by Accenture (NYSE: ACN) in September, 2012. Prior to founding Octagon, Jim worked as a Regulatory Affairs professional at both Johnson & Johnson and Schering-Plough.

Jim is a graduate of Villanova University earning a B.S. in Science Comprehensive. Jim also earned an M.S. in Environmental Science from Rutgers University and an M.B.A. from Duke University and his Doctorate degree from the University of Pennsylvania. His dissertation was an exploratory study on adaptability in the workplace.

Jim served on the Board of Directors for the Cadient Group, acquired by Cognizant (Nasdaq: CTSH) in October, 2014. Jim is also the Chairman of TrialScope, Inc. and Zoomi, Inc. He also serves on the Advisory board of EmeraldStage2 ventures.